A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The study will assess the safety, tolerability and efficacy of CSJ137 in chronic hemodialysis patients. It is hypothesized that treatment with CSJ137 may improve the level of hemoglobin in patients on chronic hemodialysis with iron-restricted anemia while reducing the need for dosing with erythropoietin and intravenous iron in these patients.
Epistemonikos ID: 03a7f169cb03464972ba1b0ceddf974436cb005b
First added on: May 12, 2024